1 / 3

Antihypertensive Drugs Market

Antihypertensive drugs market to reach $28,797 million by 2026 at a CAGR of 3.1%, Calcium channel blockers segment holds the largest market share

Shrikantchavan725
Télécharger la présentation

Antihypertensive Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antihypertensive Drugs Market Antihypertensive drugs industry was pegged at $22.56 billion in 2018 and is projected to reach $28.79 billion by 2026, registering a CAGR of 3.1% from 2019 to 2026. Driving factors for the market Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global antihypertensive drugs market. However, patent expirations of blockbuster drugs hamper the market growth. On the contrary, high growth potential in developing countries is expected to create lucrative opportunities in the near future. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/436 The ACE inhibitors segment to manifest fastest CAGR through 2026 The ACE inhibitors segment is projected to register the fastest CAGR of 4.7% during the forecast period, owing to the positive impact these drugs have on the overall health and extensive use of ACE inhibitors in various types of hypertension. However, the calcium channel blockers segment held the largest share in 2018, contributing to more than one-fourth of the global antihypertensive drugs market, owing to lesser side effects exhibited by these drugs as compared to the other type of antihypertensive drugs. The hospital pharmacy segment held the largest share The hospital pharmacy segment dominated the market in 2018, accounting for more than half of the global antihypertensive drugs market, owing to increase in the number of hospitalized NASH patients, surge in number of hospital pharmacies, improvement in structure of hospital pharmacies in the emerging

  2. countries such as China and India. However, the e-commerce websites & online drug stores segment is projected to register the fastest CAGR of 4.2% during the study period, due to surge in preference for online purchasing of drugs over the traditional methods, rise in the number of Internet users, and increase in awareness of online pharmacy. North America dominated the market The global antihypertensive drugs market across North America held the largest share in 2018, accounting for more than one-third of the market, owing to the availability of the antihypertensive drugs and rise in prevalence of hypertension due to surge in geriatric population in the region. However, the market across the Asia-Pacific region is anticipated to portray the fastest CAGR of 4.2% during the forecast period, owing to surge in awareness related to use of antihypertensive drugs and the presence of active key players in the region. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/436 Major market players Boehringer Ingelheim GmbH Johnson and Johnson Merck KGaA Pfizer, Inc. Bayer AG AstraZeneca plc Takeda Pharmaceutical Co., Ltd. Sanofi S.A. Daiichi Sankyo Company

  3. Novartis International AG

More Related